– Severity Outcomes among Adult Patients with Primary Immunodeficiency and COVID-19 Seen in Emergency Departments, United States, April 2020–August 2021
– GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
– A Randomized Controlled Study Assessing Convalescent Immunoglobulins versus Convalescent Plasma for Hospitalized COVID-19 Patients
– Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
– Vaccines and therapeutics for immunocompromised patients with COVID-19
– COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
– Vaccines and therapeutics for immunocompromised patients with COVID-19
– Cellular and molecular biomarkers of long COVID: a scoping review
Inmunidad y covid-19: inmunodeficiencias, biomarcadores, inmunoterapias, vacunas…
En la sección: COVID-19, Infectología, Inmunidad innata, Inmunodeficiencias, Inmunoterapia, Vacunología. Publicado en: . 
Haga un comentario